xi's moments
Home | Companies

Novozymes OneHealth cultivates global probiotic market to help develop industry

chinadaily.com.cn | Updated: 2023-05-29 13:37

The booth of Novozymes OneHealth at the 2023 China Gut Conference in Beijing. [Photo provided to chinadaily.com.cn]

The main businesses of OneHealth are currently gastrointestinal health, brain health, immune health, metabolism and oral health. In the development of probiotic products, OneHealth has bacterial strain products including Lactobacillus reuteri DSM17648, Bifidobacterium longum 35624 and Bifidobacterium longum 1714.

|<< Previous 1 2 3 4 5 6 Next   >>|
Global Edition
BACK TO THE TOP
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349